Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Colorectal Neoplasms

Free Subscription 16.03.2026 1 Am J Surg 2 Ann Surg 8 Ann Surg Oncol 1 Anticancer Res 2 BMC Cancer 2 BMC Gastroenterol 1 Br J Cancer 1 Br J Surg 3 Cancer Lett 3 Cancer Res 2 Eur J Cancer 1 Eur J Gastroenterol Hepatol 13 Eur J Surg Oncol 5 Gastroenterology 4 Gastrointest Endosc 1 Gut 1 Hum Pathol 4 Int J Cancer 1 Int J Colorectal Dis 3 Int J Oncol 1 J Am Coll Surg 2 J Clin Oncol 3 J Natl Cancer Inst 2 J Pathol 4 J Surg Oncol 1 Oncogene 1 Oncology 6 PLoS One 2 Proc Natl Acad Sci U S A 2 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. EROZKAN K, Karahan S, Rosen DR, Klingler M, et al
   Over a decade with Transanal Minimally Invasive Surgery (TAMIS): Analyzing short- and long-term oncological outcomes of 208 patients with rectal lesions.
   Am J Surg. 2026;254:116852.
   PubMed         Abstract available
   
   

   
   Ann Surg

2. ROUANET P, Guerrieri M, Lemercier P, Balik E, et al
   A Prospective European Trial Comparing Laparotomy, Laparoscopy, Robotic-assisted, and Transanal Total Mesorectal Excision Procedures in High-risk Patients With Rectal Cancer: The RESET Trial.
   Ann Surg. 2026;283:697-706.
   PubMed         Abstract available
   
   
3. SHIRAISHI T, Nishizawa Y, Nakajima M, Kado R, et al
   Prospective Multicenter Study to Clarify the Frequency of Peristomal Skin Disorders and Appropriate Evaluation Time in Patients With Malignant Rectal Tumors.
   Ann Surg. 2026;283:687-696.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. CHINEN Y, Hata T, Takeda M, Sekido Y, et al
   Clinical Significance of Bromodomain-Containing Protein 9 in Colorectal Cancer.
   Ann Surg Oncol. 2026 Mar 12. doi: 10.1245/s10434-026-19336.
   PubMed         Abstract available
   
   
5. HOPPING E, Gauci E, Brown K, Bhimani N, et al
   ASO Visual Abstract: Circulating Extracellular Vesicle Biomarkers as Diagnostic and Prognostic Biomarkers of Liver Metastasis in Colorectal Cancer: A Systematic Review.
   Ann Surg Oncol. 2026 Mar 2. doi: 10.1245/s10434-026-19164.
   PubMed        
   
   
6. MOROCHO B, Lightfoot S, Somasundar P, Kwon S, et al
   ASO Visual Abstract: Trends and Outcomes of Liver-First Surgical Approach in Patients with Colorectal Cancer and Isolated Liver Metastases.
   Ann Surg Oncol. 2026 Mar 2. doi: 10.1245/s10434-026-19320.
   PubMed        
   
   
7. VAN DEN HEUVEL TBM, Rauwerdink P, Hulshof E, van de Vlasakker VCJ, et al
   Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II Trial.
   Ann Surg Oncol. 2026;33:3004-3017.
   PubMed         Abstract available
   
   
8. BOYSEN M, Lai SH, Byers S, Widmar M, et al
   Rectal Cancer Watch-and-Wait Management of Patients With Tumors Within Versus Beyond the Reach of Digital Rectal Examination.
   Ann Surg Oncol. 2026;33:2856-2864.
   PubMed         Abstract available
   
   
9. FOLKERT IW, Mehran R, Sun R, Morris VK, et al
   Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial.
   Ann Surg Oncol. 2026;33:2899-2907.
   PubMed         Abstract available
   
   
10. ZMUC J, Heil J, Herfarth C, Bechstein WO, et al
    Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates.
    Ann Surg Oncol. 2023;30:7624-7632.
    PubMed         Abstract available
    
    
11. WU H, Wang S, Lv H, Lou F, et al
    Effect of Thoracic Epidural Anesthesia on Perioperative Neutrophil Extracellular Trapping Markers in Patients Undergoing Anesthesia and Surgery for Colorectal Cancer: A Randomized, Controlled Trial.
    Ann Surg Oncol. 2023;30:7561-7568.
    PubMed         Abstract available
    
    

    
    Anticancer Res

12. TAKCI RG, Sarac B, Hacisuleyman L, Sahinbas B, et al
    Synergistic Anticancer Effects of the PLK1 Inhibitor BI-2536 and beta-Glucan in Colon and Gastric Cancer Cells.
    Anticancer Res. 2026;46:1461-1474.
    PubMed         Abstract available
    
    

    
    BMC Cancer

13. ZHAO F, Lin H, Han R, Wang M, et al
    Genetic landscape of Chinese colorectal cancer: insights into germline and somatic mutations.
    BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15626.
    PubMed        
    
    
14. GAO X, Zhang H, Wang Y, Hu P, et al
    Network pharmacology and molecular docking analysis on mechanisms of Euphorbia Lathyris L. seed in treating colorectal cancer.
    BMC Cancer. 2026 Mar 11. doi: 10.1186/s12885-026-15778.
    PubMed        
    
    

    
    BMC Gastroenterol

15. WANG W, Zhang X, Wang M, Wang L, et al
    Profile and diagnostic value of N6-methyladenosine-related mRNA regulators in colorectal adenoma and colorectal cancer.
    BMC Gastroenterol. 2026 Mar 5. doi: 10.1186/s12876-026-04722.
    PubMed        
    
    
16. WANG Z, Wang Z, Han S, Wang E, et al
    Correlation between liver fat fraction measured by MRI IDEAL-IQ sequence and ALT, GGT, and AST in colorectal cancer patients after chemotherapy.
    BMC Gastroenterol. 2026 Mar 9. doi: 10.1186/s12876-026-04690.
    PubMed        
    
    

    
    Br J Cancer

17. LI M, Li Y, Li C, Liu A, et al
    Dynamic reorganisation of intratumoural bacterial florae during colorectal cancer progression.
    Br J Cancer. 2026 Mar 6. doi: 10.1038/s41416-026-03344.
    PubMed         Abstract available
    
    

    
    Br J Surg

18. SPOLVERATO G, Fassan M, Scarpa M, Stepanyan A, et al
    IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer.
    Br J Surg. 2023;110:1490-1501.
    PubMed         Abstract available
    
    

    
    Cancer Lett

19. HU C, Cai D, You W, Zhou Z, et al
    Multi-Omics Driven Immune Classification of Colorectal Cancer: Implications for Immunotherapy Efficacy Prediction and Enhancement With WNT Signaling Inhibition.
    Cancer Lett. 2026 Mar 10:218425. doi: 10.1016/j.canlet.2026.218425.
    PubMed         Abstract available
    
    
20. WANG Y, Li D, Wei D, Miao G, et al
    STAU1-mediated stabilization of ITGB5 enhances FOXP3 transcriptional activity to form a self-reinforcing metastasis circuit in colorectal cancer.
    Cancer Lett. 2026 Mar 6:218407. doi: 10.1016/j.canlet.2026.218407.
    PubMed         Abstract available
    
    
21. HOLDFELDT A, Salerno S, Johansson E, Frisk E, et al
    Disabling aggressive colorectal cancer by dual targeting of cancer cells and the microenvironment.
    Cancer Lett. 2026;646:218397.
    PubMed        
    
    

    
    Cancer Res

22. GARCIA-RODRIGUEZ JL, Korsgaard U, Ahmadov U, Jarlstad Olesen MT, et al
    Spatial Profiling of Circular RNAs in Cancer Reveals High Expression in Muscle and Stromal Cells.
    Cancer Res. 2023;83:3340-3353.
    PubMed         Abstract available
    
    
23. XIA Z, De Vuyst F, Ernst S, Suwal U, et al
    PI3K and MAPK Signaling Nodes Serve as Divergent Drivers of Phenotypic Plasticity in Cancer-Associated Fibroblasts in Colorectal Cancer.
    Cancer Res. 2026 Mar 12. doi: 10.1158/0008-5472.CAN-25-0766.
    PubMed         Abstract available
    
    
24. LI W, Peng J, He J, Liao L, et al
    PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-Enhancer Formation.
    Cancer Res. 2026 Mar 5. doi: 10.1158/0008-5472.CAN-25-3520.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

25. AL-TOMA D, Kemna R, Ali M, Zwart K, et al
    Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial.
    Eur J Cancer. 2026;238:116668.
    PubMed         Abstract available
    
    
26. SHKURTI J, van den Berg K, van Erning FN, Lahaye MJ, et al
    Diagnostic accuracy of CT for local staging of colon cancer: A nationwide study in the Netherlands.
    Eur J Cancer. 2023;193:113314.
    PubMed         Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

27. TARIQ MA, Malik AF
    Burden of premature mortality from colorectal cancer among Asian Americans: years of life lost analysis.
    Eur J Gastroenterol Hepatol. 2026;38:521-522.
    PubMed        
    
    

    
    Eur J Surg Oncol

28. CERDAN-SANTACRUZ C, Cano-Valderrama O, Santos Rancano R, Teres LB, et al
    "Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study".
    Eur J Surg Oncol. 2023;49:106962.
    PubMed         Abstract available
    
    
29. ARJONA-SANCHEZ A, Aziz O, Passot G, Salti G, et al
    Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry.
    Eur J Surg Oncol. 2023;49:107001.
    PubMed         Abstract available
    
    
30. BORG J, Garm Spindler KL, Havelund BM, Sorensen MM, et al
    Risk factors and outcome following salvage surgery for squamous cell carcinoma of the anus.
    Eur J Surg Oncol. 2023;49:107050.
    PubMed         Abstract available
    
    
31. PISO T, Gerken M, Benz SR, Klinkhammer-Schalke M, et al
    Elective surgery in rectal cancer: long term results of a German network comparison of open, laparoscopic, and robotic surgery.
    Eur J Surg Oncol. 2026;52:111383.
    PubMed         Abstract available
    
    
32. ZHAO Y, Chen Z, Wei Y, Zhou J, et al
    Clinical-radiological predictive model for preoperative risk stratification in rectal adenocarcinoma.
    Eur J Surg Oncol. 2026;52:111398.
    PubMed         Abstract available
    
    
33. GARFINKLE R, Balvardi S, Carmichael H, Shorr R, et al
    Outcomes reported in randomized controlled trials of rectal cancer treatment: A scoping review for the CORRECT initiative.
    Eur J Surg Oncol. 2026;52:111416.
    PubMed         Abstract available
    
    
34. WANG Q, Xu L, Li B, Popuri K, et al
    Improved risk stratification in patients with colorectal liver metastases by incorporating volumetric body composition analysis.
    Eur J Surg Oncol. 2026;52:111402.
    PubMed         Abstract available
    
    
35. CASHIN PH, Morris D, Esquivel J, Larsen SG, et al
    The clinical benefit of a near complete cytoreduction in patients with colorectal peritoneal metastases: a propensity score matched study.
    Eur J Surg Oncol. 2026;52:111437.
    PubMed         Abstract available
    
    
36. NOIRET B, Kepenekian V, Leroy M, Provost M, et al
    Surgery for Colorectal Peritoneal Metastases in non-expert centers is strongly associated with tumor persistence or early recurrence: a bicentric study of 106 patients.
    Eur J Surg Oncol. 2026;52:111397.
    PubMed         Abstract available
    
    
37. KITAGUCHI D, Forgione A, Innocenzi C, Yang Y, et al
    The role of complete mesocolic excision with central vascular ligation in colon cancer surgery: A systematic review and meta-analysis of prospective trials.
    Eur J Surg Oncol. 2026;52:111516.
    PubMed         Abstract available
    
    
38. SCARDINO A, Wolthuis A, Taffurelli G, Dileo C, et al
    Readmission rates and predictive factors in older patients undergoing colorectal cancer surgery: A multicenter European retrospective study.
    Eur J Surg Oncol. 2026;52:111497.
    PubMed         Abstract available
    
    
39. MARTINEZ BRAVO JJ, Gogenur M, Gogenur I, Kiran RP, et al
    A prediction model for disease-free survival following R0/R1 rectal cancer resection: A retrospective longitudinal study based on the Norwegian and Danish colorectal cancer quality registries.
    Eur J Surg Oncol. 2026;52:111514.
    PubMed         Abstract available
    
    
40. SARTI K, El-Rawadi E, Gelli M, Beunon P, et al
    Targeting the liver: Insights from a tertiary center on post-operative hepatic arterial oxaliplatin for metastatic colorectal cancer.
    Eur J Surg Oncol. 2026;52:111511.
    PubMed         Abstract available
    
    

    
    Gastroenterology

41. HANSCOM M
    Cold Snare Polypectomy for Small Colorectal Polyps-Quick and Safe.
    Gastroenterology. 2023;165:1302.
    PubMed         Abstract available
    
    
42. KETOVER SR
    Comments on "Can Colonoscopy Still Be Promoted as the Best Choice for Colorectal Cancer Screening?".
    Gastroenterology. 2026 Mar 3:S0016-5085(26)00201.
    PubMed        
    
    
43. KONG C, Jin Y, Guo F, Yang Y, et al
    Revealing the Antagonistic Interactions of Faecalibacterium prausnitzii and Bacteroides fragilis in Colorectal Cancer.
    Gastroenterology. 2026 Mar 6:S0016-5085(26)00002.
    PubMed         Abstract available
    
    
44. ZHANG M, Chen C, Lu Z, Cai Y, et al
    Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms.
    Gastroenterology. 2023;165:1151-1167.
    PubMed         Abstract available
    
    
45. ALBRECHT T, Rossberg A, Albrecht JD, Nicolay JP, et al
    Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma.
    Gastroenterology. 2023;165:1262-1275.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

46. HIRAI M, Yanai S, Kunisaki R, Nishio M, et al
    Effectiveness of endoscopic resection for colorectal neoplasms in ulcerative colitis: a multicenter registration study.
    Gastrointest Endosc. 2023;98:806-812.
    PubMed         Abstract available
    
    
47. KAWABATA Y, Kudo SE, Maeda Y, Kuroki T, et al
    Clinical impact of combination of lesion-border findings and pit patterns for identifying invasive versus noninvasive neoplastic lesions in ulcerative colitis.
    Gastrointest Endosc. 2026;103:520-529.
    PubMed         Abstract available
    
    
48. DE SIRE R, Alfarone L, Capogreco A, Massimi D, et al
    A novel, thin-needle knife with high-pressure waterjet for colorectal underwater endoscopic submucosal dissection (with video).
    Gastrointest Endosc. 2026;103:605-612.
    PubMed         Abstract available
    
    
49. CHAVES J
    Fecal immunochemical test strategies: Is quantitative testing the only way forward in colorectal cancer screening?
    Gastrointest Endosc. 2026;103:518-519.
    PubMed        
    
    

    
    Gut

50. WU CT, Targher G, Byrne CD, Younossi ZM, et al
    Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement.
    Gut. 2026 Jan 21:gutjnl-2025-337374. doi: 10.1136/gutjnl-2025-337374.
    PubMed         Abstract available
    
    

    
    Hum Pathol

51. BAHCECI D, Choi WT
    Recent updates and debates on basal crypt dysplasia, serrated epithelial change, and p53 immunostaining in inflammatory bowel disease.
    Hum Pathol. 2025 Oct 24:105959. doi: 10.1016/j.humpath.2025.105959.
    PubMed         Abstract available
    
    

    
    Int J Cancer

52. HAO J, Dai S, Wang M, Zhou J, et al
    Association of predicted body compositions with the risk of colorectal cancer in the Chinese population: A 15-year prospective cohort.
    Int J Cancer. 2026 Mar 5. doi: 10.1002/ijc.70404.
    PubMed         Abstract available
    
    
53. LI RR, Li B, Yang XL, Zhou HJ, et al
    Fruquintinib with programmed cell death - 1 inhibitors versus triflueridine - tipiracil - 102 with bevacizumab in late-line mCRC: A retrospective cohort study based on propensity score matching.
    Int J Cancer. 2026;158:2253-2259.
    PubMed         Abstract available
    
    
54. MONAHAN KJ, Fleming P, Ryan NAJ, Monje-Garcia L, et al
    Outcomes from the English National Lynch Syndrome transformation project.
    Int J Cancer. 2026;158:2369-2379.
    PubMed         Abstract available
    
    
55. LEI J, Falcaro M, Brentnall AR, O'Mahony JF, et al
    Indicators to identify cancer screening providers with suboptimal case detection: A scoping review.
    Int J Cancer. 2026;158:2339-2358.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

56. LV L, Zheng J, Shi A, Lu J, et al
    Robot-assisted surgery for colorectal cancer using Weigao versus da Vinci systems: a retrospective comparative study.
    Int J Colorectal Dis. 2026 Mar 12. doi: 10.1007/s00384-026-05116.
    PubMed         Abstract available
    
    

    
    Int J Oncol

57. TENTORI L, Leonetti C, Muzi A, Dorio AS, et al
    [Corrigendum] Influence of MLH1 on colon cancer sensitivity to poly(ADP?ribose) polymerase inhibitor combined with irinotecan.
    Int J Oncol. 2026;68:55.
    PubMed         Abstract available
    
    
58. WU S, Wu F, Li X, Jiang Z, et al
    Smoking promotes colorectal cancer via the CKAP2L/AREG axis.
    Int J Oncol. 2026;68:59.
    PubMed         Abstract available
    
    
59. LIN H, Feng J, Chen P, Hu J, et al
    lncRNA AL445238.2?USP4 axis regulates cell survival and stemness in colon cancer.
    Int J Oncol. 2026;68:45.
    PubMed         Abstract available
    
    

    
    J Am Coll Surg

60. HILL MB, Tawantanakorn T, Gonen M, Abbass MA, et al
    Risk of Metachronous Colorectal Cancer After Segmental or Extended Resection in Patients with Lynch Syndrome.
    J Am Coll Surg. 2026 Mar 3. doi: 10.1097/XCS.0000000000001892.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

61. OWENS CA, Ludmir EB, Liu Q, Qiu W, et al
    Reply to: Methodologic Considerations for Subsequent Colorectal Cancer in Survivors of Childhood Cancer.
    J Clin Oncol. 2026 Mar 11:JCO2600051. doi: 10.1200/JCO-26-00051.
    PubMed        
    
    
62. LIU Y, Liu Y, Wei Y
    Methodologic Considerations for Subsequent Colorectal Cancer in Survivors of Childhood Cancer.
    J Clin Oncol. 2026 Mar 11:JCO2502569. doi: 10.1200/JCO-25-02569.
    PubMed        
    
    

    
    J Natl Cancer Inst

63. HAAS CB, Engels EA, Horner MJ, Pfeiffer RM, et al
    Cumulative incidence of anal cancer since HIV or AIDS diagnosis in the United States.
    J Natl Cancer Inst. 2023;115:1227-1230.
    PubMed         Abstract available
    
    
64. BRENNER H, Holland-Letz T, Kopp-Schneider A, Heisser T, et al
    Early-detection and prevention effects of screening sigmoidoscopy: evidence from randomized trials revisited.
    J Natl Cancer Inst. 2026;118:422-428.
    PubMed         Abstract available
    
    
65. OPHOFF D, Bos D, van Heek T, Witteman BJ, et al
    Liver fat and clinical outcomes in individuals with stage I-III colon or rectal cancer.
    J Natl Cancer Inst. 2026;118:466-475.
    PubMed         Abstract available
    
    

    
    J Pathol

66. HAN Q, Liu L, Wang J, Deng J, et al
    Roles of THBS2(+) fibroblasts in malignant transformation of colorectal polyp to cancer.
    J Pathol. 2026;268:445-459.
    PubMed         Abstract available
    
    
67. VAN DE WEERD S, Torang A, Zwager LW, Koelink PJ, et al
    Consensus molecular subtype transition during progression of colorectal cancer.
    J Pathol. 2023;261:298-308.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

68. TROESTER A, Guidolin K, Frebault J, Mott SL, et al
    Biology or Technical Error? Association Between Microsatellite Instability and Positive Margins in Stage I-III Colon Cancer.
    J Surg Oncol. 2026 Mar 5. doi: 10.1002/jso.70224.
    PubMed         Abstract available
    
    
69. LIN WL, Wu LM, Huang WT, Guo HR, et al
    Age as a modifier of the effects of sarcopenia on survival among colon cancer patients after surgery.
    J Surg Oncol. 2023;128:1121-1132.
    PubMed         Abstract available
    
    
70. VAN DORP M, Unal S, Gooijer S, Dickhoff C, et al
    Salvage surgery for local recurrences after stereotactic ablative radiotherapy of colorectal pulmonary metastases.
    J Surg Oncol. 2023;128:1114-1120.
    PubMed         Abstract available
    
    
71. VARLAMOS CJ, Sinco B, Van Weiren I, Regenbogen S, et al
    Close distal margin is associated with locoregional rectal cancer recurrence: A multicenter study.
    J Surg Oncol. 2023;128:1106-1113.
    PubMed         Abstract available
    
    

    
    Oncogene

72. PENG Z, Ma B, Song Z, Zhao Y, et al
    PMM2 interacts with TRIM28 to recruit E2F4 and promote KIFC3-mediated tumor glycolysis and colorectal cancer progression.
    Oncogene. 2026 Mar 6. doi: 10.1038/s41388-026-03707.
    PubMed         Abstract available
    
    

    
    Oncology

73. BARDAKCI M, Demirtas Esmer D, Hafizoglu E, Yaslikaya S, et al
    Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically.
    Oncology. 2023;101:723-729.
    PubMed         Abstract available
    
    

    
    PLoS One

74. HOAD KL, Ton C, Williamson D, Subar DA, et al
    The role of prehabilitation in improving brain health and cognition after chemotherapy in patients with colorectal cancer: Study protocol of the Chemo Brain Prehab Project.
    PLoS One. 2026;21:e0341996.
    PubMed         Abstract available
    
    
75. FARAHMAND P, Rzasa P, Green C, Hey F, et al
    Phosphorylations of serines 21/9 in glycogen synthase kinase 3alpha/beta are dispensable for V600EBRAF-driven premalignant tumour development in the mouse intestine.
    PLoS One. 2026;21:e0337259.
    PubMed         Abstract available
    
    
76. DE KLERK M, Bartels EA, Timmers J, Nahar-van Venrooij LMW, et al
    Person-centered care, shared decision-making, and service modularity in colorectal cancer treatment: A mixed-method study of patient and professional perspectives.
    PLoS One. 2026;21:e0343331.
    PubMed         Abstract available
    
    
77. LI J, Zhang J, Ke J, Ren Z, et al
    Integrative network pharmacology and machine learning identify potential targets of indole-3-lactic acid in colorectal cancer.
    PLoS One. 2026;21:e0344478.
    PubMed         Abstract available
    
    
78. VILKOITE I, Silamikelis I, Klovins J, Tolmanis I, et al
    Colorectal adenoma presence is associated with decreased menaquinone pathway functions in the gut microbiome of patients undergoing routine colonoscopy.
    PLoS One. 2026;21:e0344050.
    PubMed         Abstract available
    
    
79. PADUANO G, Di Giuseppe G, Postiglione M, Nese G, et al
    Assessment of the adherence and willingness to participate in colorectal cancer screening programs among people living in prison.
    PLoS One. 2026;21:e0344256.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

80. LEVINE MS, Li J, Ehrlich LIR, DePinho RA, et al
    Viral mimicry may help explain immunogenic cell death.
    Proc Natl Acad Sci U S A. 2026;123:e2537547123.
    PubMed         Abstract available
    
    
81. WEBER LI, Timpen LE, Egger-Horschinger AS, Schopf P, et al
    Reactivation of the silenced BASP1 gene suppresses oncogenic WNT signaling in human colorectal cancer cells.
    Proc Natl Acad Sci U S A. 2026;123:e2524159123.
    PubMed         Abstract available
    
    

    
    World J Surg

82. TAKAMOTO T, Nara S, Ban D, Mizui T, et al
    Objective Definition and Optimized Strategy for "Biologically Borderline Resectable" Colorectal Liver Metastases.
    World J Surg. 2023;47:2834-2845.
    PubMed         Abstract available
    
    
83. WIESLER B, Worni M, Studer P, Gass JM, et al
    How Is Colorectal Cancer Care Impacted by Global Crisis in Contrasting Healthcare Systems?-A Descriptive Study From Scotland and Switzerland During the COVID-19 Pandemic.
    World J Surg. 2026 Mar 2. doi: 10.1002/wjs.70294.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum